Sirona Biochem Corp.
SBM.V
TSX
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.90K | 8.20K | 1.20K | -23.20K | 5.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.90K | 8.20K | 1.20K | -23.20K | 5.10K |
| Cost of Revenue | -- | -- | 12.50K | 11.10K | -- |
| Gross Profit | 1.90K | 8.20K | -11.30K | -34.30K | 5.10K |
| SG&A Expenses | 145.80K | 251.30K | 298.30K | 187.90K | 242.40K |
| Depreciation & Amortization | 1.90K | 1.80K | 1.80K | 1.90K | 1.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 482.50K | 289.90K | 488.10K | 394.80K | 333.10K |
| Operating Income | -480.70K | -281.70K | -486.90K | -418.00K | -328.00K |
| Income Before Tax | -645.10K | -308.50K | -541.70K | -464.10K | -394.50K |
| Income Tax Expenses | 1.40K | -500.00 | 400.00 | 800.00 | -500.00 |
| Earnings from Continuing Operations | -646.40K | -308.00K | -542.10K | -464.90K | -394.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -646.40K | -308.00K | -542.10K | -464.90K | -394.00K |
| EBIT | -480.70K | -281.70K | -486.90K | -418.00K | -328.00K |
| EBITDA | -478.80K | -279.90K | -485.10K | -416.10K | -321.60K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 258.65M | 254.32M | 253.60M | 252.39M | 252.18M |
| Average Diluted Shares Outstanding | 258.65M | 254.32M | 253.60M | 252.39M | 252.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
